🇺🇸 FDA

Company profile · Sponsor

Mineralys

Mineralys Therapeutics

MLYS · NYSE pharma RADNOR, PA, USA
Pipeline
7
Drugs
0
Patents
0

Quick answer

Mineralys (MLYS) is a pharma company. headquartered in RADNOR, PA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker MLYS
Exchange NYSE
Company type pharma
Headquarters RADNOR, PA, USA
SEC CIK 0001933414

Pipeline (7)

Search pipeline →

  1. Lorundrostat Placebo Tablets, Lorundrostat, Synacthen 0,25 mg/ml Injektionslösung, Lorundrostat

    Mineralys

    Uncontrolled and Resistant Hypertension

    phase 3 small molecule active

    1 trial

  2. Lorundrostat, Lorundrostat, Synacthen 0,25 mg/ml Injektionslösung, Lorundrostat Placebo tablet, Lorundrostat

    Mineralys

    Hypertension

    phase 3 small molecule active

    1 trial

  3. Placebo

    Mineralys

    Hypertension

    phase 3 small molecule completed

    2 trials

  4. lorundrostat

    Mineralys

    Hypertension

    phase 3 small molecule active

    1 trial

  5. Lorundrostat

    Mineralys

    Obstructive Sleep Apnea

    phase 2 small molecule completed

    1 trial

  6. Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD

    Mineralys

    Chronic Kidney Disease

    phase 2 small molecule completed

    1 trial

  7. MLS-101 (Part I)

    Mineralys

    Hypertension, Renal

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Mineralys?

Mineralys (MLYS) is a pharma company. headquartered in RADNOR, PA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Mineralys sponsor?

We track 7 ClinicalTrials.gov-linked programs for Mineralys, including Lorundrostat Placebo Tablets, Lorundrostat, Synacthen 0,25 mg/ml Injektionslösung, Lorundrostat and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Mineralys company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.